Search Results for 'statin risk'

statin risk published presentations and documents on DocSlides.

Tailoring Statin Therapy in Women
Tailoring Statin Therapy in Women
by lois-ondreau
Under-Representation of Women . in Clinical Trial...
Statin Adherence Purpose
Statin Adherence Purpose
by ivy
Outline the issue of medication nonadherence and r...
Statin Side effects   Active treatment
Statin Side effects   Active treatment
by ximena
Control. Relative risk. Absolute Effect. (per thou...
Risk factors in  heart disease
Risk factors in heart disease
by faustina-dinatale
Optimizing . patient care. William Cromwell, MD, ...
2013 ACC/AHA  Guidelines:
2013 ACC/AHA Guidelines:
by belinda
Blood . Cholesterol And. Assessment of Cardiovascu...
The State of
The State of
by olivia-moreira
Dyslipidemia. . Treatment. USA-145-101385. © . ...
Updates on the Management of Dyslipidemia
Updates on the Management of Dyslipidemia
by ellena-manuel
A Review of the 2013 ACC/AHA Cholesterol Guidelin...
Moderate-Intensity Statins for Dyslipidemia: How to Treat Today?
Moderate-Intensity Statins for Dyslipidemia: How to Treat Today?
by danika-pritchard
2013 ACC/AHA Cholesterol Guidelines. Statin Initi...
Update:  Lipid Guidelines
Update: Lipid Guidelines
by yoshiko-marsland
DO NOT BURN THE COOKIES. Amy R. Woods, M.D.. a. ...
 Application of the Data:
Application of the Data:
by giovanna-bartolotta
Cardiometabolic Disease Is an Epidemic. Clinical ...
Cardiology Wade  Laudenschlager
Cardiology Wade Laudenschlager
by matterguy
, MD. Acute Respiratory Failure. CAUSES- Anatomic ...
The New  Cholesterol Guidelines:
The New Cholesterol Guidelines:
by lily
Beauty is in the Eye of the Beholder. Brian Asbill...
LDL is causal of atherosclerosis
LDL is causal of atherosclerosis
by morgan
Evidence from . meta-analyses of . Mendelian. . r...
Lipid Treatment Updates in Management
Lipid Treatment Updates in Management
by TheCookieMonster
Debra Griner, MS FNP-C. Mesa Primary Care. Casper,...
SWL lipid management guideline update- Highlights
SWL lipid management guideline update- Highlights
by finley
 . Pedro Bandeira. Specialist Pharmacist- Cardiov...
In The Name Of God Dyslipidemia
In The Name Of God Dyslipidemia
by PinkPandaBear
/Lipid management in . Diabetes. Dr.Zahra. . davo...
VOL 61OCTOBEROCTOBRE 2015 Canadian Family PhysicianLe Mdecin de fam
VOL 61OCTOBEROCTOBRE 2015 Canadian Family PhysicianLe Mdecin de fam
by jovita
Simplied lipid guidelinesPrevention and manag...
UMHS Lipid Therapy GuidelineJuly 2020
UMHS Lipid Therapy GuidelineJuly 2020
by arya
Quality Department Guidelines for Clinical Care Am...
Treatment of Blood  Cholesterol
Treatment of Blood Cholesterol
by daniella
to Reduce Atherosclerotic Cardiovascular . Risk in...
In the Name of  God Management
In the Name of God Management
by genevieve
of. Dyslipidemia. Navid Saadat, MD. Associate Pro...
American Heart Association, November 13, 2023, Philadelphia, PA
American Heart Association, November 13, 2023, Philadelphia, PA
by bella
Inflammation and Cholesterol as Predictors of Card...
Raging Controversies in CVD
Raging Controversies in CVD
by gelbero
Risk Assessment and Cholesterol Management. Roger ...
National Lipid Association
National Lipid Association
by taylor
Recommendations for Patient-Centered Management of...
Implementing UCLPartners Familial Hypercholesterolemia Searches and Screening
Implementing UCLPartners Familial Hypercholesterolemia Searches and Screening
by ceila
Dr Deep Shah, . Clinical. . Lead UCL Partners. Do...
Lipid management
Lipid management
by phoebe-click
د. حسين محمد جمعة . اختصاØ...
Primary Prevention
Primary Prevention
by marina-yarberry
Nice Guidelines . Who to offer therapy to?. Offer...
Modelling of endpoint postponement for all-cause mortality
Modelling of endpoint postponement for all-cause mortality
by cheryl-pisano
Morten . Rix . Hansen. Anton Pottegård . Asbjør...
Cholesterol Treatment Trialists’ (CTT) Collaboration
Cholesterol Treatment Trialists’ (CTT) Collaboration
by briana-ranney
Slide deck. CTT Collaboration: Background*. Histo...
PCSK-9 Inhibitors Paul J
PCSK-9 Inhibitors Paul J
by tatyana-admore
PCSK-9 Inhibitors Paul J Kovack , DO, FACC, FACO...
Putting Your Skills to the Test
Putting Your Skills to the Test
by deborah
Which ONE of the following statements regarding th...
Clinical  case Age 74  years
Clinical case Age 74 years
by joy
Sex . Male. Diabetes. . History. T2D, . onset. @...
James Yarmolinsky, PhD Drug-target Mendelian randomization and dementia risk
James Yarmolinsky, PhD Drug-target Mendelian randomization and dementia risk
by emery
(opportunities and challenges). Advanced Research ...
Diabetes is not an homogeneous risk:        The role of coronary calcium score in the reclassificat
Diabetes is not an homogeneous risk: The role of coronary calcium score in the reclassificat
by spiderslipk
 . JOSEPH SHEMESH MD. The Grace . Ballas. Cardia...
New concepts and guidelines in the management of LDL-c and CV Risk:
New concepts and guidelines in the management of LDL-c and CV Risk:
by cappi
Need for early intervention. Prof. . Ulf . Landmes...
Heart Disease in the HIV
Heart Disease in the HIV
by oneill
+. Person. Ted Gibbons, MD. January 15, 2015. Sec...
Protecting the heart and the kidney:
Protecting the heart and the kidney:
by marina-yarberry
Implications from the SHARP trial. Dr. Christina ...
Hypertension & Cholesterol
Hypertension & Cholesterol
by cheryl-pisano
Blake Wachter, MD, PhD. Idaho Heart Institute. Ep...
Is lower better? LDL targets and beyond.
Is lower better? LDL targets and beyond.
by trish-goza
Implications of the relationship between risk fac...